Abstract
This study was conducted to compare the post-operative analgesic efficacy and safety of Bupivacaine and Ropivacaine through epidural route after spine surgeries. It includes 100 patients, randomly allocated into two groups B & R, 50 patients for each group. Patients with ASA class I and II between the age of 18 and 60 years of both sexes were included. Group B patients received Bupivacaine 0.125%, 2ml/ segment and Group R patient received Ropivacaine 0.2% 2ml/segment, depending on incision length. The difference in mean baseline VAS score between the two groups was not found to be statistically significant. A VAS score of 0 reached at 22 mins in Ropivacaine compared to 24 mins in group Bupivacaine and lasted till 90 minutes as compared to 28 minutes in group B. thereafter also higher mean VAS scores were observed in group B (Bupivacaine) until the entire period of observation (240 minutes). Ropivacaine was found to be significantly more effective onset of analgesia (5.36±1.30 min and7.32±2.03min) peak level of analgesia (17.22±2.30 min and 21.36±2..54). And requirement of supplemental analgesia less than bupivacaine. Motor blockade assessed by the mean modified Bromage score was significantly less in Group Ropivacaine as compared to that observed in group Bupivacaine. These drugs were comparable in terms of haemodynamic parameters. This study concludes that Ropivacaine 0.2% was more efficient analgesic than Bupivacaine 0.125% in epidural anaesthesia.
Keywords: Ropivacaine, Bupivacaine, analgesia, epidural and spinal surgery.
References
- Bianconi M, Ferraro L, Ricci R, Zanoli G, Antonelli T, Giulia B, et al. The pharmacokinetics and efficacy of ropivacaine continuous wound instillation after spine fusion surgery. Anesth Analg. 2004;98:166–72. [PubMed]
- Taenzer AH, Clark C. Efficacy of postoperative epidural analgesia in adolescent scoliosis surgery: A meta-analysis. Paediatr Anaesth. 2010;20:135–43. [PubMed]
- Bajwa SJS, Haldar R. Pain management following spinal surgeries: An appraisal of the available options. Journal of Craniovertebral Junction & Spine. 2015;6(3):105-110.
- Hansen TG. Ropivacaine: A pharmacological review. Expert Rev Neurother. 2004;4:781–91. [PubMed]
- Cox CR, Faccenda KA, Gilhooly C, Bannister J, Scott NB, Morrison LMM. Extradural S(-)Bupivacaine: comparision with racemic RS bupivacaine. Br J Anaesth.1998;80: 289 –93. [PubMed]
- Kuthiala G, Chaudhary G. Ropivacaine: A review of its pharmacology and clinical use. Indian Journal of Anaesthesia. 2011;55(2):104-110.
- Sawhney KY, Kundra S, Grewal A, Katyal S, Singh G, Kaur A. A Randomized Double Blinded Comparison of Epidural Infusion of Bupivacaine, Ropivacaine, Bupivacaine-Fentanyl, Ropivacaine-Fentanyl for Postoperative Pain Relief in Lower Limb Surgeries. Journal of Clinical and Diagnostic Research : JCDR. 2015;9(9):UC19-UC23.
- Meghana S, Garima A, Madhavi S, Preet K, Karishma B. Efficacy of bupivacaine and ropivacaine for postoperative analgesia in continuous epidural infusion in lower limb surgeries under combined spinal-epidural analgesia. Anaesth Pain & Intensive Care 2017;21(3):360-36
- Bindra TK, Singh R, Gupta R. Comparison of postoperative pain after epidural anesthesia using 0.5%, 0.75% ropivacaine and 0.5% bupivacaine in patients undergoing lower limb surgery: A double-blind study. Anesth Essays Res 2017;11:52-6
- Paddalwar S, Nagrale M, Chandak M, Shrivastava D, Papalkar J. A randomized, double-blind, controlled study comparing bupivacaine 0.125% and ropivacaine 0.125%, both with Fentanyl 2 ug/ml, for labor epidural analgesia. Indian J Pain 2013;27:147
- Peduto VA, Baroncini S, Montanini S, et al. A prospective, randomized, double-blind comparison of epidural levobupivacaine 0.5% with epidural ropivacaine 0.75% for lower limb procedures. Eur J Anaesthesiol.2003;20 :979–83. [PubMed]
- McGlade DP, Kalpokas MV, Mooney PH, Buckland MR, Vallipuram SK, Hendrata MV, et al. Comparison of 0.5% ropivacaine and 0.5% bupivacaine in lumbar epidural anaesthesia for lower limb orthopaedic surgery. Anaesth Intensive Care. 1997;25:262–6. [PubMed]
- Zaric D., Nydahl P.-A., Philipson L., Samuelsson L., Heierson A., Axelsson K. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers: A double-blind study. 1996;21(1):14–25. [PubMed]
- Berti M, Fanelli G, Casati A, Albertin A, Palmisano S, Deni F, et al. Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/ fentanyl or ropivacaine/fentanyl. Can J Anaesth. 2000;47(1):27–32. [PubMed]
- Surabathuni S, Venugopalan, Rao. VT, Nageswararao P.A Comparative Study of Post Operative Epidural Analgesia Between 0.125% Bupivacaine And 0.2% Ropivacaine in Lower Limb Surgeries. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS).2015;14(9) 37-43.
- Chandran S, Hemalatha S, Viswanathan P. Comparison of 0.75% ropivacaine and 0.5% bupivacaine for epidural anaesthesia in lower extremity orthopaedic surgeries. Indian Journal of Anaesthesia. 2014;58(3): 336-338.
- Bindra TK, Singh R, Gupta R. Comparison of postoperative pain after epidural anesthesia using 0.5%, 0.75% ropivacaine and 0.5% bupivacaine in patients undergoing lower limb surgery: A double-blind study. Anesth Essays Res 2017;11:52-6
- Simpson D, Curran MP, Oldfield V, Keating GM. Ropivacaine: A review of its use in regional anaesthesia and acute pain management. Drugs. 2005;65:2 675–717. [PubMed]
- Graf BM, Abraham I, Eberbach N, Kunst G, Stowe DF, Martin E. Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physicoche-mical and stereoselective properties. Anesthesiology.2002;96: 1427–34. [PubMed]
- Knudsen K, Beckman Suurküla M, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507–14. [PubMed]
Corresponding Author
Dr Chilaka Murali
Associate Professor, Department of Anaesthesia, Kakatiya Medical College, Warangal, Telanana State, India
DOI: https://dx.doi.org/10.18535/jmscr/v7i6.32
